Alessandro Lupini

Brescia, 25123, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Dopaminergic nigrostriatal vulnerability in Parkinson's Disease with diabetes: evidence from severity-matched cohorts.

Dopaminergic nigrostriatal vulnerability in Parkinson's Disease with diabetes: evidence from severity-matched cohorts.

Journal: European journal of nuclear medicine and molecular imaging

Published: March 13, 2026

Association between plasma glucosylsphingosine levels and dyskinesia burden in GBA1-related Parkinson's disease.

Association between plasma glucosylsphingosine levels and dyskinesia burden in GBA1-related Parkinson's disease.

Journal: Neurobiology of disease

Published: November 22, 2025

Clustering Algorithm Reveals Dopamine-Motor Mismatch in Cognitively Preserved Parkinson's Disease.

Clustering Algorithm Reveals Dopamine-Motor Mismatch in Cognitively Preserved Parkinson's Disease.

Journal: Annals of clinical and translational neurology

Published: July 05, 2025

Plasma NfL, GFAP, and pTau181 in patients with isolated REM sleep behavior disorder.

Plasma NfL, GFAP, and pTau181 in patients with isolated REM sleep behavior disorder.

Journal: Sleep

Published: October 30, 2024

Biofluid Markers and Tissue Biopsies Analyses for the Prodromal and Earliest Phase of Parkinson's Disease.

Biofluid Markers and Tissue Biopsies Analyses for the Prodromal and Earliest Phase of Parkinson's Disease.

Journal: Journal of Parkinson's disease

Published: September 27, 2024

Insular monoaminergic deficits in prodromal α-synucleinopathies.

Insular monoaminergic deficits in prodromal α-synucleinopathies.

Journal: Annals of clinical and translational neurology

Published: June 04, 2024

Plasma NfL, GFAP, amyloid, and p-tau species as Prognostic biomarkers in Parkinson's disease.

Plasma NfL, GFAP, amyloid, and p-tau species as Prognostic biomarkers in Parkinson's disease.

Journal: Journal of neurology

Published: May 17, 2024

Increased glucosylsphingosine levels and Gaucher disease in GBA1-associated Parkinson's disease.

Increased glucosylsphingosine levels and Gaucher disease in GBA1-associated Parkinson's disease.

Journal: Parkinsonism & related disorders

Published: March 05, 2024

The p.Val234Met LRP10 likely pathogenic variant associated with Parkinson's disease: Possible molecular implications.

The p.Val234Met LRP10 likely pathogenic variant associated with Parkinson's disease: Possible molecular implications.

Journal: Parkinsonism & related disorders

Published: February 12, 2024

Heterozygous APTX mutation associated with atypical multiple system atrophy-like phenotype: A case report.

Heterozygous APTX mutation associated with atypical multiple system atrophy-like phenotype: A case report.

Journal: Parkinsonism & related disorders

Published: December 13, 2023

Occipital atrophy signature in prodromal Lewy bodies disease.

Occipital atrophy signature in prodromal Lewy bodies disease.

Journal: Alzheimer's & dementia (Amsterdam, Netherlands)

Published: April 20, 2023

Atypical brain FDG-PET patterns increase the risk of long-term cognitive and motor progression in Parkinson's disease.

Atypical brain FDG-PET patterns increase the risk of long-term cognitive and motor progression in Parkinson's disease.

Journal: Parkinsonism & related disorders

Published: April 01, 2023

Showing 1-12 of 13

Last Updated: 09/26/2026